Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,175 trials

NCT07110376
Recruiting
Deep Brain Stimulation Neural Recordings of Varied Stimulation During Sleep in Parkinson's Disease
Not applicable · United States · 1 site
Registry update: 28 Aug 2026
NCT07532395
Recruiting
FMS-CrossFit Training Program (FCTP) to Improve School Readiness in Preschool Children With Autism Spectrum Disorder
Not applicable · China · 2 sites
Registry update: 20 Oct 2026
2023-508548-23-00
Recruiting
Phase III clinical trial to evaluate the efficacy and safety of specific immunotherapy with mannanconjugated allergoids for the treatment of rhinitis/rhinoconjunctivitis in patients allergic to house dust mites.
Phase 3 · Spain, Portugal · 18 sites
Registry update: 22 Jul 2026
NCT07532824
Recruiting
Proton-Based Total Marrow Irradiation for Allogeneic Transplantation in High-Risk AML/MDS
Phase 1/2 · Czechia · 2 sites
Registry update: 16 Apr 2026
NCT06441773
Recruiting
Impact of Respiratory Rehabilitation on Quality of Life in Patients With Metastatic Non-small Cell Lung Cancer Treated With Immunotherapy and Chemotherapy in the Maintenance Phase
Not applicable · France · 3 sites
Registry update: 17 Jun 2026
NCT07301411
Recruiting
Exploratory Trial of Navigational Bronchoscopy-Guided Cryoablation in Lung Cancer Treatment
Not applicable · China, Hong Kong · 2 sites
Registry update: 24 Dec 2025
NCT07523048
Recruiting
Dextromethorphan-Bupropion on Striatal Activity in Adults With Major Depressive Disorder
Phase 2 · Canada · 1 site
Registry update: 13 Apr 2026
NCT07638007
Recruiting
Impact of Targeted Therapy on Cancer-Related Cognitive Impairment
Not applicable · United States · 1 site
Registry update: 10 Jun 2026
NCT07328425
Recruiting
Clinical Study in Adult and Young Adult Patients With Advanced Desmoplastic Small Round Cell Tumor (DSRCT) ISG-TULIPS
Phase 2 · Spain, Italy · 11 sites
Registry update: 3 Nov 2026
NCT07232875
Recruiting
HRS 4642 Injection Combined With AG Versus Placebo Combined With AG Therapy in First-Line Advanced or Metastatic Pancreatic Cancer
Phase 3 · China · 1 site
Registry update: 26 Oct 2026
NCT06945484
Recruiting
PILOT for The Precision Exercise Regimen for Cancer Care (PERCC) Study
Not applicable · United States · 2 sites
Registry update: 3 Nov 2026
NCT07325240
Recruiting
24-hour Effect of Rocklatan Compared With Latanoprost in Open Angle Glaucoma and Ocular Hypertension Patients
Phase 4 · United States · 1 site
Registry update: 1 May 2026
NCT06153069
Recruiting
Asymptomatic TB With Innovative Modified Short-course Regimens
Phase 4 · China · 5 sites
Registry update: 11 Feb 2026
NCT07389629
Recruiting
Iparomlimab and Tuvonralimab (QL1706) Combination With Lenvatinib as Neoadjuvant Therapy for ccRCC
Phase 2 · China · 1 site
Registry update: 5 Feb 2026
NCT07159061
Recruiting
Neurofeedback to Treat Depression - 2
Not applicable · United States · 1 site
Registry update: 4 Dec 2025
NCT07232433
Recruiting
Safety and Efficacy Evaluation of Cryoablation in the Treatment of Ground-Glass Nodules
Not applicable · China · 1 site
Registry update: 22 Jan 2026
NCT07103018
Recruiting
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
Phase 1 · United States · 13 sites
Registry update: 20 Oct 2026
NCT07300150
Recruiting
A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors
Phase 1 · South Korea, United States · 9 sites
Registry update: 6 Jul 2026
NCT06890338
Recruiting
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
Phase 2 · United States · 73 sites
Registry update: 20 Oct 2026
NCT07231757
Recruiting
The RADIANCE CED Study
Not applicable · United States · 2 sites
Registry update: 16 Jul 2026

Ordered by registry start date. Freshness and sponsorship never change the order.